“In people who have diabetes, when they’re on GLP-1s, they experience an early increase in the risk of diabetic retinopathy,” ...

India faces a diabetes crisis with 101 million affected, yet insulin use is hampered by myths. Experts urge timely insulin ...

Toowoomba needs and deserves a public eye unit as part of the new Toowoomba Hospital so elderly patients no longer need to be ...

Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...

Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a ...

Scientists have discovered that human stomach cells can be genetically reprogrammed to act like pancreatic beta cells and produce insulin. This approach could one day help people with Type 1 diabetes ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide.

4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and ...

4D Molecular Therapeutics (4DMT) released positive interim 1.5- to 3.5-year data from the phase 1/2 PRISM clinical trial ...

4D-150 delivers a prolonged, sustained release of anti-vascular endothelial growth factor (anti-VEGF) from the retina with ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and ...